The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - Leukemia, 2019 - nature.com
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …
被引用次数：38 相关文章

[引用][C] The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - Leukemia, 2019 - cir.nii.ac.jp
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - Leukemia, 2019 - europepmc.org
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - …, 2019 - sure.sunderland.ac.uk
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - Leukemia, 2019 - go.gale.com
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - …, 2019 - pubmed.ncbi.nlm.nih.gov
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

M Kahl, A Brioli, M Bens, F Perner, A Kresinsky… - …, 2019 - sure.sunderland.ac.uk
To date, only one subtype of acute myeloid leukemia (AML), acute promyelocytic leukemia
(APL) can be effectively treated by differentiation therapy utilizing all-trans retinoic acid …